Skip to Main Content

Residents & Fellows

Yale School of Medicine/

Yale Cancer Center

Yale Cancer Center

Patient Information
- Cancer Types
  Chênevert Family Brain Tumor Center
  Center for Breast Cancer
  Endocrine Cancers Program
  Center for Gastrointestinal Cancers
  Gynecologic Oncology Program
  Head & Neck Cancers Program
  Hematology Program
  Liver Cancer Program
  Skin & Kidney Cancer Program
  Pediatric Hematology & Oncology Program
  Prostate & Urologic Cancers Program
  Sarcoma Program
  Center for Thoracic Cancers
- Specialty Programs
  Cancer Genetics and Prevention
  Screening & Prevention
  Early Onset Cancer Program
  Early Onset Cancers
  Programs
  Resources
  Research
  PROSPER
  Cardio-Oncology
  Integrative Medicine
  Interventional Oncology
  Ocular Oncology
  Onco-Dermatology
  Pain Program
  Palliative Care
  Psycho-Oncology
  Sexuality, Intimacy & Menopause Program
  Survivorship Clinic
  Tobacco Treatment
News

Research & Education
Make a Gift

About Us
Contact Us

Diversity
Intranet

INFORMATION FOR

About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni

Back to Alessandro Santin, MD

Publications

Featured and Publish Date (Newest First)
Publish Date: Newest to Oldest
Publish Date: Oldest to Newest
Title: A-Z
Title: Z-A
Most Cited
Most Discussed

Showing 1 of 1 Publications

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas
Black JD, Lopez S, Cocco E, Bellone S, Altwerger G, Schwab CL, English DP, Bonazzoli E, Predolini F, Ferrari F, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas. British Journal Of Cancer 2015, 113: 1020-1026. PMID: 26325104, PMCID: PMC4651122, DOI: 10.1038/bjc.2015.306.
Peer-Reviewed Original Research
MeSH Keywords and Concepts

Download Full List

Filter By

Authors

Showing applied filters for Yale Authors:

Showing results for Top Yale Co-Authors:

Masoud Azodi(1)

Organizations

Showing results for Most published Organizations:

Obstetrics, Gynecology & Reproductive Sciences(1)
Yale Cancer Center(1)

Categories

Peer-Reviewed Original Research(1)

Publish Date

From

To

MeSH Keywords

Showing results for Top tagged Keywords:

Biomarkers, Tumor(1)
Uterine Neoplasms(1)
Cystadenocarcinoma, Serous(1)
Receptor, ErbB-2(1)
Phosphatidylinositol 3-Kinases(1)

Concepts

Showing applied filters for Concepts:

Showing results for Top Concepts:

Cell lines(101)
Ovarian cancer(95)
Endometrial cancer(86)
Cancer(64)
Patients(61)

Yale Cancer Center
PO Box 208028
New Haven, CT 06520-8028
Maps & Directions
188 Events
you could attend in November 2024
Calendar
Contact Us

Intranet
Site Editor
Accessibility at YSM
Nondiscrimination & Title IX
Safety & Security
Terms & Privacy Statement
Yale University

© 2024 Yale School of Medicine. Updated 09/17/2024

Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads